| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-11 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-09 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-08 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-08 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-08 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-07 |